Astellas Pharma Inc

This study tests the safety of a monthly eye injection called ASP3021 in 20 Japanese adults aged 40 and older who have geographic atrophy, an advanced form of age-related macular degeneration that causes vision loss. Participants receive injections into the affected eye for 12 mo…

This study tests a new drug, ASP5834, in people with advanced solid tumors that have certain changes in the KRAS gene. The goal is to find a safe dose and check for side effects. Some participants with colorectal cancer will also receive another drug called panitumumab. The study…

This study is observing 3000 people with rheumatoid arthritis who are starting peficitinib for the first time. Researchers are tracking side effects and how well the drug controls disease activity in real-world settings. The goal is to understand the drug's safety and effectivene…

This study tests a new drug, ASP2246, for adults who have trouble moving after a stroke. It is the first time this drug is used in humans. The study has two parts: first, finding safe doses by giving the drug directly to the brain during surgery; second, comparing the drug to a s…

This early-phase study tests a new drug, ASP3082, in people with advanced solid tumors that have a specific genetic change called KRAS G12D. The main goals are to check safety and find the best dose, either alone or combined with another drug (cetuximab). About 681 participants w…